Sentence examples for status trial from inspiring English sources

Furthermore, center status, trial size and funding will be assessed.

Two of the four reviewers used a standardised form to extract in duplicate data on publication status, trial design, patients' characteristics, treatment regimens, outcome modalities, and funding.

In the randomised controlled trials there was also no clear evidence of heterogeneity according to several trial characteristics (for example, amount and type of intervention, blinding status, trial size, or duration of follow-up), except for some evidence that larger studies tended to yield more extreme relative risks (see supplementary fig 12b).

These included several trials that primarily aimed to improve symptoms or functional status, trials that tested interventions with a considerable potential for causing harm (mainly bleeding) that were not meaningfully measured, and trials with composite outcomes that were dominated by outcomes of questionable importance to patients.

As our data suggest that an aggressive chemotherapy might have a negative impact on survival of patients with poor performance status, trials to evaluate the activity of new regimens should be conducted separately for each subset of patients with different performance status.

18 Bias domains from the Cochrane risk of bias tool (selection bias, performance bias, detection bias, attrition bias and reporting bias), and further centre status, trials size and source of funding risk positively influencing an experimental treatment if they are found inadequate or unclear.

Then, ongoing and terminated trials were removed based on their status and/or trial reports.

These metaregressions relied in part on assumptions about the EGFR mutation status of trial populations.

Again, there were no significant differences when patients were compared by menopausal status at trial entry.

3 The protocol should explicitly state who will be blinded to intervention groups at a minimum, the blinding status of trial participants, care providers, and outcome assessors.

Response to treatment did not appear to be influenced by disease type (HD/NHL), response to previous chemotherapy or disease status at trial entry.